192 related articles for article (PubMed ID: 33649538)
1. The RanBP2/RanGAP1-SUMO complex gates β-arrestin2 nuclear entry to regulate the Mdm2-p53 signaling axis.
Blondel-Tepaz E; Leverve M; Sokrat B; Paradis JS; Kosic M; Saha K; Auffray C; Lima-Fernandes E; Zamborlini A; Poupon A; Gaboury L; Findlay J; Baillie GS; Enslen H; Bouvier M; Angers S; Marullo S; Scott MGH
Oncogene; 2021 Mar; 40(12):2243-2257. PubMed ID: 33649538
[TBL] [Abstract][Full Text] [Related]
2. p53 SUMOylation promotes its nuclear export by facilitating its release from the nuclear export receptor CRM1.
Santiago A; Li D; Zhao LY; Godsey A; Liao D
Mol Biol Cell; 2013 Sep; 24(17):2739-52. PubMed ID: 23825024
[TBL] [Abstract][Full Text] [Related]
3. Mdm2-mediated ubiquitination of β-arrestin2 in the nucleus occurs in a Gβγ- and clathrin-dependent manner.
Zhang X; Min X; Wang S; Sun N; Kim KM
Biochem Pharmacol; 2020 Aug; 178():114049. PubMed ID: 32450252
[TBL] [Abstract][Full Text] [Related]
4. Nucleocytoplasmic shuttling of p53 is essential for MDM2-mediated cytoplasmic degradation but not ubiquitination.
O'Keefe K; Li H; Zhang Y
Mol Cell Biol; 2003 Sep; 23(18):6396-405. PubMed ID: 12944468
[TBL] [Abstract][Full Text] [Related]
5. C-terminal modifications regulate MDM2 dissociation and nuclear export of p53.
Carter S; Bischof O; Dejean A; Vousden KH
Nat Cell Biol; 2007 Apr; 9(4):428-35. PubMed ID: 17369817
[TBL] [Abstract][Full Text] [Related]
6. Regulation of p53 nuclear export through sequential changes in conformation and ubiquitination.
Nie L; Sasaki M; Maki CG
J Biol Chem; 2007 May; 282(19):14616-25. PubMed ID: 17371868
[TBL] [Abstract][Full Text] [Related]
7. In situ SUMOylation analysis reveals a modulatory role of RanBP2 in the nuclear rim and PML bodies.
Saitoh N; Uchimura Y; Tachibana T; Sugahara S; Saitoh H; Nakao M
Exp Cell Res; 2006 May; 312(8):1418-30. PubMed ID: 16688858
[TBL] [Abstract][Full Text] [Related]
8. Reconstitution of the Recombinant RanBP2 SUMO E3 Ligase Complex.
Ritterhoff T; Das H; Hao Y; Sakin V; Flotho A; Werner A; Melchior F
Methods Mol Biol; 2016; 1475():41-54. PubMed ID: 27631796
[TBL] [Abstract][Full Text] [Related]
9. SUMO regulates p21Cip1 intracellular distribution and with p21Cip1 facilitates multiprotein complex formation in the nucleolus upon DNA damage.
Brun S; Abella N; Berciano MT; Tapia O; Jaumot M; Freire R; Lafarga M; Agell N
PLoS One; 2017; 12(6):e0178925. PubMed ID: 28582471
[TBL] [Abstract][Full Text] [Related]
10. SUMO-1 modification and its role in targeting the Ran GTPase-activating protein, RanGAP1, to the nuclear pore complex.
Matunis MJ; Wu J; Blobel G
J Cell Biol; 1998 Feb; 140(3):499-509. PubMed ID: 9456312
[TBL] [Abstract][Full Text] [Related]
11. beta-arrestin 2 oligomerization controls the Mdm2-dependent inhibition of p53.
Boularan C; Scott MG; Bourougaa K; Bellal M; Esteve E; Thuret A; Benmerah A; Tramier M; Coppey-Moisan M; Labbé-Jullié C; Fåhraeus R; Marullo S
Proc Natl Acad Sci U S A; 2007 Nov; 104(46):18061-6. PubMed ID: 17984062
[TBL] [Abstract][Full Text] [Related]
12. SUMO-specific protease 2 in Mdm2-mediated regulation of p53.
Jiang M; Chiu SY; Hsu W
Cell Death Differ; 2011 Jun; 18(6):1005-15. PubMed ID: 21183956
[TBL] [Abstract][Full Text] [Related]
13. Importin-β and CRM1 control a RANBP2 spatiotemporal switch essential for mitotic kinetochore function.
Gilistro E; de Turris V; Damizia M; Verrico A; Moroni S; De Santis R; Rosa A; Lavia P
J Cell Sci; 2017 Aug; 130(15):2564-2578. PubMed ID: 28600321
[TBL] [Abstract][Full Text] [Related]
14. DNA damage-induced heterogeneous nuclear ribonucleoprotein K sumoylation regulates p53 transcriptional activation.
Pelisch F; Pozzi B; Risso G; Muñoz MJ; Srebrow A
J Biol Chem; 2012 Aug; 287(36):30789-99. PubMed ID: 22825850
[TBL] [Abstract][Full Text] [Related]
15. Determinants of small ubiquitin-like modifier 1 (SUMO1) protein specificity, E3 ligase, and SUMO-RanGAP1 binding activities of nucleoporin RanBP2.
Gareau JR; Reverter D; Lima CD
J Biol Chem; 2012 Feb; 287(7):4740-51. PubMed ID: 22194619
[TBL] [Abstract][Full Text] [Related]
16. Nuclear export is required for degradation of endogenous p53 by MDM2 and human papillomavirus E6.
Freedman DA; Levine AJ
Mol Cell Biol; 1998 Dec; 18(12):7288-93. PubMed ID: 9819415
[TBL] [Abstract][Full Text] [Related]
17. T-cell receptor (TCR) signaling promotes the assembly of RanBP2/RanGAP1-SUMO1/Ubc9 nuclear pore subcomplex via PKC-θ-mediated phosphorylation of RanGAP1.
He Y; Yang Z; Zhao CS; Xiao Z; Gong Y; Li YY; Chen Y; Du Y; Feng D; Altman A; Li Y
Elife; 2021 Jun; 10():. PubMed ID: 34110283
[TBL] [Abstract][Full Text] [Related]
18. Sumoylation of Mdm2 by protein inhibitor of activated STAT (PIAS) and RanBP2 enzymes.
Miyauchi Y; Yogosawa S; Honda R; Nishida T; Yasuda H
J Biol Chem; 2002 Dec; 277(51):50131-6. PubMed ID: 12393906
[TBL] [Abstract][Full Text] [Related]
19. Methods to Investigate the Nucleocytoplasmic Shuttling Properties of β-Arrestins.
Blondel-Tepaz E; Guilbert T; Scott MGH
Methods Mol Biol; 2019; 1957():251-269. PubMed ID: 30919359
[TBL] [Abstract][Full Text] [Related]
20. The MDM2 RING-finger domain is required to promote p53 nuclear export.
Geyer RK; Yu ZK; Maki CG
Nat Cell Biol; 2000 Sep; 2(9):569-73. PubMed ID: 10980696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
